ArticlePharmacoEconomics - open2024

Cost-Effectiveness Analysis of Abrocitinib Compared with Other Systemic Treatments for Severe Atopic Dermatitis in Spain.

Rosa María Romero Jiménez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.